news & press

02/15/2012
DePuy Orthopaedics, Inc. (DePuy) has received Premarket (PMA) Supplement Approval from the U.S. Food and Drug Administration (FDA) for use of TRUMATCH® Personalized Solutions with DePuy’s SIGMA® RP Knee System.
02/08/2012

DePuy Orthopaedics, Inc. (DePuy) announced the launch of several new advancements in orthopaedics spanning joint replacement, shoulder reconstruction and hip revision surgery, each designed to optimize or streamline procedures, personalize care and provide clinical and economic value.

12/29/2011

On December 12, 2011, Codman & Shurtleff, Inc., and Symmetry Medical Inc. announced a definitive agreement for Symmetry to acquire Codman’s instruments portfolio and market these products under the Symmetry Surgical name. This transaction is limited to Codman’s instruments portfolio, which includes reusable stainless steel and titanium surgical instruments and retractor systems, sterile disposable surgical products (vein strippers, SECTO dissectors, tonsil sponges and surgical marker pens), and sterilization containers. This agreement was completed on December 29, 2011

12/12/2011

Codman & Shurtleff, Inc., has entered into a definitive agreement with Specialty Surgical Instrumentation, Inc. (SSI), a wholly owned subsidiary of Symmetry Medical Inc. (Symmetry), by which Symmetry will acquire Codman’s instruments business, and market these products under the Symmetry name.

12/12/2011

Next Generation Polyethylene Bearing for DePuy's Rotating Platform Knees is Designed For Optimal Wear Resistance, Long-Term Oxidative Stability

12/06/2011

 
DePuy Spine, Inc. today announced the launch of the EXPEDIUM® Neuromuscular System, a new modular system of pre-contoured rods and proximal connectors, open and closed iliac screw designs and wires, designed to help surgeons address spinal and pelvic deformity in patients with neuromuscular scoliosis.
 

11/14/2011

Codman & Shurtleff, Inc. (Codman), a global neuroscience and neurovascular company, today announced the launch of the CODMAN® CERTAS™ Programmable Valve, a shunt used in the treatment of congenital or acquired hydrocephalus, an excess accumulation of cerebrospinal fluid (CSF) in the brain.

09/19/2011

DePuy Orthopaedics, Inc. (DePuy), a global leader in devices for joint replacement, is pleased that results released in the 2011 Annual Report of the National Joint Registry of England and Wales (UK NJR) confirm the continued clinical success of current DePuy hip and knee joint replacement products. These devices help patients who have been affected by pain, disability and a loss of mobility return to their daily activities.

09/15/2011

The Anatomy of Movement Experience Features a Walk-Through Exhibit of the Hip and Knee and Inspirational Stories from Joint Replacement Patients

WARSAW, IN (Sept. 15, 2011) – Motivated by her behind-the-scenes struggle with severe hip pain, Emmy®-nominated actress and bilateral hip replacement patient Jane Kaczmarek is joining forces with DePuy Orthopaedics, Inc. (DePuy) to launch the Anatomy of Movement Experience, an educational program that demonstrates the disabling effects of osteoarthritis and encourages those suffering with severe knee or hip pain to start a conversation with a doctor about their treatment options.

09/14/2011

Public Education Symposium To Be Held Tonight in Raynham

As part of National Brain Aneurysm Awareness Month, Codman & Shurtleff, Inc. (Codman), a global neurovascular and neuroscience company, is teaming up with the Brain Aneurysm Foundation to host a public education symposium, “What You Want to Know About Brain Aneurysm Treatment & Recovery,” at the DePuy Institute, LLC, the company’s research and education facility.

Media Contacts

Find media contact information for DePuy and our companies.

click here for ASR Recall information

Feb 22 2012 - 15:26:18